In this pink month of October, Val-de-Marne wants to further develop its medical infrastructure. After visiting the Gustave-Rousse Institute, arrive in Villejuif on the 4th^e ranking of the world’s best hospitals specializing in cancer treatment, new Paris Saclay Cancer Cluster Research Center (PSCC) is scheduled to open its doors in 2024 in the center of “Campus Grand Parc” in Villejuif (Val-de-Marne).

A multi-partner initiative

This new building, called “HIVE” will take place at the PSCC, a research center created in 2022 at the initiative of the Institut Gustave-Roussy Sanofi, the University of Paris-Saclay, Inserma and the École Polytechnique de Paris. HIVE – Paris Saclay Cancer Cluster should be able to host more than 1600 researchers in an environment entirely dedicated to research and medical innovation.

HIVE will not only integrate various laboratories, but also offices, common areas and services for various beneficiaries of the facilities. SMEs and start-ups related to medical research and life sciences will actually be located in the premises, located at 116 rue Édouard Vaillant, Villejuif.

A strategic location as it will be in the center of the Villejuif “Biocluster”. The building must be located right next to the Gustave-Rousse Institute. At the helm we find Sadev 94, the urban planning service responsible for Villejuif’s “hospitable city” and Kadans, the real estate specialist of the scientific research center. Kadan will also be able to celebrate with this building the opening of its first building in France.

Follow all the news from your favorite cities and media by subscribing to Mon Actu.